RedDress Announces Randomized Controlled Trial Results Showing Significant Benefits of ActiGraft Pro for Diabetic Foot Ulcers Patients treated with ActiGraft Pro from RedDress are more than twice as likely to heal compared with those receiving standard of care per a new study.

Real World Evidence (RWE) Solutions Market Analysis 2024: Drug and Medical Device Development and Approvals - Global Forecast to 2029 Dublin, March 19, 2024 (GLOBE NEWSWIRE) -- The "Global Real World Evidence Solutions Market by Component (Services, Disparate Data Sets (Clinical), Application (Drug and Medical Device Development...

Global Real World Evidence Solutions Market to 2028: Increased Emphasis on Comprehensive RWE Services Drives Growth Dublin, April 03, 2023 (GLOBE NEWSWIRE) -- The "Global Real World Evidence Solutions Market Size, Share & Industry Trends Analysis Report By Component, By Therapeutic Area, By End-user, By...

New Study Shows Superior Healing Outcomes Associated with Ultrasonic Debridement FARMINGDALE, N.Y., July 09, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ:MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...